Contact Lens Wearer
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Bausch + LombNJ - Bridgewater
3 programsAll participants received Biotrue ONEday lenses with and without an alternate packaging solutionN/A1 trial
kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9DN/A1 trial
samfilcon A Lenses with EPG01 Packaging SolutionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bausch + Lombsamfilcon A Lenses with EPG01 Packaging Solution
Bausch + LombAll participants received Biotrue ONEday lenses with and without an alternate packaging solution
Bausch + Lombkalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D
Clinical Trials (3)
Total enrollment: 138 patients across 3 trials
2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses
Start: Sep 2021Est. completion: Sep 202130 patients
N/ACompleted
NCT05129488Bausch + LombAll participants received Biotrue ONEday lenses with and without an alternate packaging solution
Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses
Start: Sep 2021Est. completion: Sep 202133 patients
N/ACompleted
NCT05129072Bausch + Lombkalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D
Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses
Start: Aug 2021Est. completion: Sep 202175 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space